1. Issue Highlights Clinical Gastroenterology and Hepatology
Joseph H. Sellin 
Clinical Gastroenterology and Hepatology 
Volume 14, Issue 3, Pages (March 2016)
DOI: /j.cgh
Copyright © 2016 AGA Institute Terms and Conditions

2. Figure 1
(A) Change in body weight after 4 and 8 weeks of treatment with placebo or mirtazapine. (B) Change in meal volume tolerance during nutrient challenge test after 8 weeks of treatment with placebo ormirtazapine. *P < .05 compared with baseline within the mirtazapine arm. †P < .05 change from baseline between treatments.
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions

3. Figure 2
Time to tTGA positivity by gluten intake (g) at the visit closest before tTGA seroconversion. Gluten intake was categorized by tertiles of quantity (ie, low [<3.4 g/d], medium [3.4–5.0 g/d], and high [>5.0 g/d]).
Clinical Gastroenterology and Hepatology  , DOI: ( /j.cgh )
Copyright © 2016 AGA Institute Terms and Conditions